Hepatocyte Growth Factor Enhances Antineoplastic Effect of 5-Fluorouracil by Increasing UPP1 Expression in HepG2 Cells

被引:4
|
作者
Okumura, Manabu [1 ,2 ]
Iwakiri, Tomomi [1 ]
Yoshikawa, Naoki [1 ]
Nagatomo, Takao [1 ]
Ayabe, Takanori [2 ,3 ]
Tsuneyoshi, Isao [2 ,4 ]
Ikeda, Ryuji [1 ]
机构
[1] Univ Miyazaki, Fac Med, Dept Pharm, Miyazaki 8891692, Japan
[2] Miyazaki Univ Hosp, Dept Patient Safety Management, Miyazaki 8891692, Japan
[3] Univ Miyazaki, Fac Med, Dept Surg, Div Thorac & Breast Surg, Miyazaki 8891692, Japan
[4] Univ Miyazaki, Fac Med, Dept Anesthesiol & Intens Care, Miyazaki 8891692, Japan
关键词
hepatocyte growth factor; HGF; 5-FU; UPP1; c-Met; erlotinib; RECEPTOR TYROSINE KINASE; C-MET; URIDINE PHOSPHORYLASE; OVEREXPRESSION; AMPLIFICATION; BINDING; CANCER; RILOTUMUMAB; SUPPRESSES; ACTIVATION;
D O I
10.3390/ijms23169108
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Aberrant activation of hepatocyte growth factor (HGF) and its receptor c-Met axis promotes tumor growth. Therefore, many clinical trials have been conducted. A phase 3 trial investigating a monoclonal antibody targeting HGF in combination with fluoropyrimidine-based chemotherapy had to be terminated prematurely; however, the reason behind the failure remains poorly defined. In this study, we investigated the influence of HGF on the antineoplastic effects of 5-fluorouracil (5-FU), a fluoropyrimidine, in HepG2 cells. HGF suppressed the proliferative activity of cells concomitantly treated with 5-FU more robustly as compared to that of cells treated with 5-FU alone, and markedly increased the expression of uridine phosphorylase 1 (UPP1). Intracellular concentration of 5-fluorouridine, an initial anabolite of 5-FU catalyzed by UPP1, was increased by HGF. Interestingly, erlotinib enhanced HGF-induced increase in UPP1 mRNA; in contrast, gefitinib suppressed it. Furthermore, erlotinib suppressed HGF-increased phosphorylation of the epidermal growth factor receptor at the Tyr1173 site involved in downregulation of extracellular signal-regulated kinase (Erk) activation, and enhanced the HGF-increased phosphorylation of Erk. Collectively, these findings suggest that inhibition of the HGF/c-Met axis diminishes the effects of fluoropyrimidine through downregulation of UPP1 expression. Therefore, extreme caution must be exercised in terms of patient safety while offering chemotherapy comprising fluoropyrimidine concomitantly with inhibitors of the HGF/c-Met axis.
引用
收藏
页数:19
相关论文
共 50 条
  • [31] Hepatocyte growth factor regulates E box-dependent plasminogen activator inhibitor type 1 gene expression in HepG2 liver cells
    Imagawa, Shogo
    Fujii, Satoshi
    Dong, Jie
    Furumoto, Tomoo
    Kaneko, Takeaki
    Zaman, Tarikuz
    Satoh, Yuki
    Tsutsui, Hiroyuki
    Sobel, Burton E.
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2006, 26 (10) : 2407 - 2413
  • [32] Overexpression of interferon regulatory factor 1 enhances chemosensitivity to 5-fluorouracil in gastric cancer cells
    Gao, Jinbo
    Tian, Yuan
    Zhang, Jinghui
    JOURNAL OF CANCER RESEARCH AND THERAPEUTICS, 2012, 8 (01) : 57 - 61
  • [33] Diverse regulations of albumin gene expression by hepatocyte growth factor in HepG2 human hepatoma cells and primary culture of rat hepatocytes
    Iseki, K
    Nakao, K
    Nakata, K
    Shima, Y
    Hamasaki, K
    Kato, Y
    Ishii, N
    Eguchi, K
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2000, 16 (06) : 1141 - 1145
  • [34] Brucine Sensitizes HepG2 Human Liver Cancer Cells to 5-fluorouracil via Fas/FasL Apoptotic Pathway
    Fan, Guoquan
    Liang, Xiaoting
    He, Yankun
    Ren, Hua
    Zhao, Jianping
    Liang, Taigang
    Wei, Jingjing
    Wang, Tong
    Zhang, Fan
    INTERNATIONAL JOURNAL OF PHARMACOLOGY, 2017, 13 (03) : 323 - 331
  • [35] Gene regulation of hepatocyte growth factor-like macrophage stimulating protein in HepG2 cells.
    Miwa, Y
    Harrison, PM
    Hughes, RD
    Bomford, AB
    Degan, SJF
    Williams, R
    HEPATOLOGY, 1996, 24 (04) : 1688 - 1688
  • [36] A FOXM1-Targeted Peptide Overcomes 5-Fluorouracil Resistance via Modulating ABC Transporters in Liver Cancer HepG2 Cells
    Guo, Hongping
    Jiang, Yuhong
    Ao, Zhiguang
    Wang, Siyi
    Mao, Canquan
    INTERNATIONAL JOURNAL OF PEPTIDE RESEARCH AND THERAPEUTICS, 2021, 27 (03) : 1815 - 1826
  • [37] A FOXM1-Targeted Peptide Overcomes 5-Fluorouracil Resistance via Modulating ABC Transporters in Liver Cancer HepG2 Cells
    Hongping Guo
    Yuhong Jiang
    Zhiguang Ao
    Siyi Wang
    Canquan Mao
    International Journal of Peptide Research and Therapeutics, 2021, 27 : 1815 - 1826
  • [38] Induction of MET protooncogene expression in HEPG2 hepatoma cell line by hepatocyte growth factor (HGF) in comparison with epidermal growth factor (EGF) and interleukin-1
    Chen, O
    Seol, D
    Zarnegar, R
    FASEB JOURNAL, 1996, 10 (06): : 1632 - 1632
  • [39] Influence of 5-fluorouracil on colonic healing and expression of transforming growth factor-β1.
    Fukuchi, SG
    Seeburger, JL
    Parquet, G
    Rolandelli, RH
    GASTROENTEROLOGY, 1998, 114 (04) : A1389 - A1389
  • [40] Repression of Nrf2 enhances antitumor effect of 5-fluorouracil and gemcitabine on cholangiocarcinoma cells
    Samatiwat, Papavee
    Prawan, Auemduan
    Senggunprai, Laddawan
    Kukongviriyapan, Veerapol
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2015, 388 (06) : 601 - 612